非急性硬膜下血肿非重症患者单独脑膜中动脉栓塞与手术引流的疗效比较。

IF 3 2区 医学 Q2 CLINICAL NEUROLOGY
Ignacio Mesina-Estarrón, Jose A Plascencia-Jimenez, Nanthiya Sujijantarat, Adam A Dmytriw, Varun Padmanaban, Sahin Hanalioglu, James D Rabinov, Christopher J Stapleton, Aman B Patel, Nirav J Patel, Mohammad A Aziz-Sultan, Rose Du, Timothy R Smith, Alfred P See, Robert W Regenhardt, Kevin Huang
{"title":"非急性硬膜下血肿非重症患者单独脑膜中动脉栓塞与手术引流的疗效比较。","authors":"Ignacio Mesina-Estarrón, Jose A Plascencia-Jimenez, Nanthiya Sujijantarat, Adam A Dmytriw, Varun Padmanaban, Sahin Hanalioglu, James D Rabinov, Christopher J Stapleton, Aman B Patel, Nirav J Patel, Mohammad A Aziz-Sultan, Rose Du, Timothy R Smith, Alfred P See, Robert W Regenhardt, Kevin Huang","doi":"10.3171/2025.7.FOCUS25468","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Middle meningeal artery embolization (MMAE) has emerged as an alternative to surgical treatment of nonacute subdural hematoma (NASDH). When used in conjunction with surgery, it has been shown to reduce recurrence, but its effectiveness as a standalone therapy remains to be established. The aim of this study was to investigate the comparative effectiveness of standalone MMAE (sMMAE) versus surgical evacuation in patients with NASDH.</p><p><strong>Methods: </strong>This retrospective propensity score-matched cohort study included consecutive patients with NASDH who underwent either sMMAE or surgical evacuation at a single institution from January 2017 to June 2024. The primary outcome was reintervention due to hematoma recurrence. Secondary outcomes included the hospital length of stay (LOS), new neurological deficits, and cardiorespiratory, neurological, and other medical adverse events.</p><p><strong>Results: </strong>Overall, 265 patients (median age 73 years) with NASDH were included. After matching, the sMMAE and surgical evacuation groups each included 85 patients. There was no baseline difference in clinical characteristics at presentation. During a median follow-up of 72 days in the sMMAE group and 59 days in the surgical group, the incidence rate of reintervention did not differ between the two treatments (incidence rate ratio [IRR] 1.38, p = 0.41). The median hospital LOS was shorter in the sMMAE group compared with the surgical evacuation group (4 days vs 6 days, p = 0.003). No differences were observed between groups in terms of new neurological deficits at 30 days (RR 0.85, p = 0.717) or the risk of cardiorespiratory (RR 0.50, p = 0.327) or neurological (RR 0.66, p = 0.657) adverse events. Patients treated with sMMAE had a lower risk of other medical adverse events compared with those treated with surgery (1.1% vs 15.2%; RR 0.07, p = 0.013).</p><p><strong>Conclusions: </strong>Patients who underwent sMMAE had shorter hospital stays and a lower risk of medical adverse events, without increased risk of recurrence, compared with patients who underwent open surgical treatment. Larger studies are warranted to establish the effectiveness of sMMAE in the management of NASDH.</p>","PeriodicalId":19187,"journal":{"name":"Neurosurgical focus","volume":"59 4","pages":"E8"},"PeriodicalIF":3.0000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparative effectiveness of standalone middle meningeal artery embolization versus surgical evacuation in noncritical patients with nonacute subdural hematomas.\",\"authors\":\"Ignacio Mesina-Estarrón, Jose A Plascencia-Jimenez, Nanthiya Sujijantarat, Adam A Dmytriw, Varun Padmanaban, Sahin Hanalioglu, James D Rabinov, Christopher J Stapleton, Aman B Patel, Nirav J Patel, Mohammad A Aziz-Sultan, Rose Du, Timothy R Smith, Alfred P See, Robert W Regenhardt, Kevin Huang\",\"doi\":\"10.3171/2025.7.FOCUS25468\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Middle meningeal artery embolization (MMAE) has emerged as an alternative to surgical treatment of nonacute subdural hematoma (NASDH). When used in conjunction with surgery, it has been shown to reduce recurrence, but its effectiveness as a standalone therapy remains to be established. The aim of this study was to investigate the comparative effectiveness of standalone MMAE (sMMAE) versus surgical evacuation in patients with NASDH.</p><p><strong>Methods: </strong>This retrospective propensity score-matched cohort study included consecutive patients with NASDH who underwent either sMMAE or surgical evacuation at a single institution from January 2017 to June 2024. The primary outcome was reintervention due to hematoma recurrence. Secondary outcomes included the hospital length of stay (LOS), new neurological deficits, and cardiorespiratory, neurological, and other medical adverse events.</p><p><strong>Results: </strong>Overall, 265 patients (median age 73 years) with NASDH were included. After matching, the sMMAE and surgical evacuation groups each included 85 patients. There was no baseline difference in clinical characteristics at presentation. During a median follow-up of 72 days in the sMMAE group and 59 days in the surgical group, the incidence rate of reintervention did not differ between the two treatments (incidence rate ratio [IRR] 1.38, p = 0.41). The median hospital LOS was shorter in the sMMAE group compared with the surgical evacuation group (4 days vs 6 days, p = 0.003). No differences were observed between groups in terms of new neurological deficits at 30 days (RR 0.85, p = 0.717) or the risk of cardiorespiratory (RR 0.50, p = 0.327) or neurological (RR 0.66, p = 0.657) adverse events. Patients treated with sMMAE had a lower risk of other medical adverse events compared with those treated with surgery (1.1% vs 15.2%; RR 0.07, p = 0.013).</p><p><strong>Conclusions: </strong>Patients who underwent sMMAE had shorter hospital stays and a lower risk of medical adverse events, without increased risk of recurrence, compared with patients who underwent open surgical treatment. Larger studies are warranted to establish the effectiveness of sMMAE in the management of NASDH.</p>\",\"PeriodicalId\":19187,\"journal\":{\"name\":\"Neurosurgical focus\",\"volume\":\"59 4\",\"pages\":\"E8\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurosurgical focus\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3171/2025.7.FOCUS25468\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurosurgical focus","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3171/2025.7.FOCUS25468","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:脑膜中动脉栓塞术(MMAE)已成为非急性硬膜下血肿(NASDH)手术治疗的替代方法。当与手术联合使用时,它已被证明可以减少复发,但其作为单独治疗的有效性仍有待确定。本研究的目的是研究独立MMAE (sMMAE)与手术引流在NASDH患者中的比较效果。方法:这项回顾性倾向评分匹配队列研究纳入了2017年1月至2024年6月在同一家机构连续接受sMMAE或手术撤离的NASDH患者。主要终点是血肿复发后的再干预。次要结局包括住院时间(LOS)、新的神经功能缺陷、心肺、神经系统和其他医疗不良事件。结果:共纳入265例NASDH患者(中位年龄73岁)。匹配后,sMMAE组和手术疏散组各包括85例患者。在首发时,临床特征没有基线差异。sMMAE组的中位随访时间为72天,手术组为59天,两种治疗的再干预发生率无差异(发生率比[IRR] 1.38, p = 0.41)。与手术疏散组相比,sMMAE组的中位住院时间更短(4天vs 6天,p = 0.003)。在30天的新神经功能缺损(RR 0.85, p = 0.717)或心肺(RR 0.50, p = 0.327)或神经系统(RR 0.66, p = 0.657)不良事件的风险方面,两组间无差异。与接受手术治疗的患者相比,接受sMMAE治疗的患者发生其他医疗不良事件的风险较低(1.1% vs 15.2%; RR 0.07, p = 0.013)。结论:与接受开放手术治疗的患者相比,接受sMMAE的患者住院时间更短,医疗不良事件风险更低,复发风险不增加。有必要进行更大规模的研究,以确定sMMAE在NASDH管理中的有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Comparative effectiveness of standalone middle meningeal artery embolization versus surgical evacuation in noncritical patients with nonacute subdural hematomas.

Objective: Middle meningeal artery embolization (MMAE) has emerged as an alternative to surgical treatment of nonacute subdural hematoma (NASDH). When used in conjunction with surgery, it has been shown to reduce recurrence, but its effectiveness as a standalone therapy remains to be established. The aim of this study was to investigate the comparative effectiveness of standalone MMAE (sMMAE) versus surgical evacuation in patients with NASDH.

Methods: This retrospective propensity score-matched cohort study included consecutive patients with NASDH who underwent either sMMAE or surgical evacuation at a single institution from January 2017 to June 2024. The primary outcome was reintervention due to hematoma recurrence. Secondary outcomes included the hospital length of stay (LOS), new neurological deficits, and cardiorespiratory, neurological, and other medical adverse events.

Results: Overall, 265 patients (median age 73 years) with NASDH were included. After matching, the sMMAE and surgical evacuation groups each included 85 patients. There was no baseline difference in clinical characteristics at presentation. During a median follow-up of 72 days in the sMMAE group and 59 days in the surgical group, the incidence rate of reintervention did not differ between the two treatments (incidence rate ratio [IRR] 1.38, p = 0.41). The median hospital LOS was shorter in the sMMAE group compared with the surgical evacuation group (4 days vs 6 days, p = 0.003). No differences were observed between groups in terms of new neurological deficits at 30 days (RR 0.85, p = 0.717) or the risk of cardiorespiratory (RR 0.50, p = 0.327) or neurological (RR 0.66, p = 0.657) adverse events. Patients treated with sMMAE had a lower risk of other medical adverse events compared with those treated with surgery (1.1% vs 15.2%; RR 0.07, p = 0.013).

Conclusions: Patients who underwent sMMAE had shorter hospital stays and a lower risk of medical adverse events, without increased risk of recurrence, compared with patients who underwent open surgical treatment. Larger studies are warranted to establish the effectiveness of sMMAE in the management of NASDH.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Neurosurgical focus
Neurosurgical focus CLINICAL NEUROLOGY-SURGERY
CiteScore
6.30
自引率
0.00%
发文量
261
审稿时长
3 months
期刊介绍: Information not localized
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信